Skip to main content
. 2017 Dec 8;9(3):3690–3703. doi: 10.18632/oncotarget.23196

Figure 1. Expression of AR, CD44/CD24 and let-7a and prognosis.

Figure 1

Immunohistochemical staining of AR positive. (A) and the negative control (B), original magnification ×200. ISH of let-7a positive (C) and the negative control (D), original magnification ×200. Double immunohistochemical staining of CD44-/CD24+ (E), CD44+/24-/low (F), CD44+/CD24+ (G) and CD44-/CD24- (H), original magnification ×400. DFS and OS curves about CD44+/24-/low (I and J), AR (K and L) and let-7a expression (M and N) status in 165 patients with invasive breast carcinoma.